- Recent Funding
- Investors
- Blackstone Life Sciences
Blackstone Life Sciences portfolio
Blackstone Life Sciences has 1 portfolio company on record at Recent Funding. Its most recent investment on record is AvenCell's $112M Series B+ round in October 2024, alongside Piper Heartland Healthcare Capital, NYBC Ventures, Novo Holdings and 2 others. That company is in Health and bio.
What Blackstone Life Sciences invests in
- Health and bio · 1 · 100%
How Blackstone Life Sciences invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $112M |
Share is of the 1 round on Recent Funding that name Blackstone Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Blackstone Life Sciences portfolio companies
| Company | Round with Blackstone Life Sciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $112M | $112M | Oct 22, 2024 Series B+ |
Most frequent co-investors
FF-Prime Capital1 shared round · last Oct 22, 2024
NNovo Holdings1 shared round · last Oct 22, 2024
NNYBC Ventures1 shared round · last Oct 22, 2024
PPiper Heartland Healthcare Capital1 shared round · last Oct 22, 2024
EEight Roads Ventures Japan1 shared round · last Oct 22, 2024
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moFFirst Imagine!1 company · 1 deal in 12 mo
MMaxis1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Blackstone Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/blackstone-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.